Skip to main content
    T

    Tarsus Pharmaceuticals Inc (TARS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $78.68
    -1.60 (-1.99%)

    Market Cap: $3.96B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tarsus Pharmaceuticals Inc (TARS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Tarsus Pharmaceuticals are Arcus Biosciences (RCUS), Arcutis Biotherapeutics (ARQT) and Telix Pharmaceuticals (TLX). By market cap, Tarsus Pharmaceuticals ranks 8th of the 13 companies on this page; Kodiak Sciences (KOD) is the largest at $7.27B.

    Peer Comparison

    TARS's ROIC of -393.6% is below the peer median of -26.2%, and its revenue growth of 63.9% is above the median of 27.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Tarsus Pharmaceuticals (TARS)$3.96BN/A5.4x-102.9%-393.6%63.9%0.00%
    Arcus Biosciences Inc (RCUS)$2.51BN/A21.5x0.0%-75.9%-65.4%0.00%
    Arcutis Biotherapeutics Inc (ARQT)$3.57B129.3x7.0x5.9%7.8%45.1%0.00%
    Telix Pharmaceuticals Limited (TLX)$3.14BN/A5.3x3.8%-0.7%22.3%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Tango Therapeutics Inc (TNGX)$4.32BN/AN/A0.0%N/A-100.0%0.00%
    Travere Therapeutics Inc (TVTX)$4.86BN/A7.2x-18.7%-23.1%36.2%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Ionis Pharmaceuticals Inc (IONS)$4.84BN/A4.8x-56.9%-29.3%54.9%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    Dianthus Therapeutics Inc. (DNTH)$5.17BN/AN/A0.0%N/A205.6%0.00%
    Xenon Pharmaceuticals Inc (XENE)$3.98BN/AN/A0.0%N/A-100.0%0.00%
    Peer median$4.15B197.9x5.3x0.0%-26.2%27.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Tarsus Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Arcus Biosciences Inc (RCUS)
    Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States.
    RCUS competitors
    Arcutis Biotherapeutics Inc (ARQT)
    Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
    ARQT competitors
    Telix Pharmaceuticals Limited (TLX)
    Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic...
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Tango Therapeutics Inc (TNGX)
    Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation...
    TNGX competitors
    Travere Therapeutics Inc (TVTX)
    Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification...
    TVTX competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Ionis Pharmaceuticals Inc (IONS)
    Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
    IONS competitors
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors
    Kodiak Sciences Inc (KOD)
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    Dianthus Therapeutics Inc. (DNTH)
    Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops...
    DNTH competitors
    Xenon Pharmaceuticals Inc (XENE)
    Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders...
    XENE competitors

    Frequently Asked Questions About TARS

    Who are Tarsus Pharmaceuticals' main competitors?

    The companies most similar to Tarsus Pharmaceuticals include Arcus Biosciences (RCUS), Arcutis Biotherapeutics (ARQT), Telix Pharmaceuticals (TLX), PTC Therapeutics (PTCT) and Tango Therapeutics (TNGX), listed from the closest match.

    Who is Tarsus Pharmaceuticals' biggest competitor?

    Kodiak Sciences (KOD) is the largest of the similar companies at $7.27B; Arcus Biosciences (RCUS) is the closest match by business profile, size, sector and industry.

    How does TARS stock compare with its competitors?

    TARS' P/S is 5.4x against a peer median of 5.3x; its net margin is -102.9% against a peer median of 0.0%.

    Which of Tarsus Pharmaceuticals' competitors pays a higher dividend?

    Tarsus Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Tarsus Pharmaceuticals bigger than its competitors?

    No. Tarsus Pharmaceuticals is 8th by market cap among the 13 companies on this page; the largest is Kodiak Sciences (KOD) at $7.27B.